OptimizeRx CorporationOPRXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+29.2%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+29.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
2025125.45%
2024-6.80%
2023-60.94%
2022-3022.37%
2021114.60%
202034.78%
2019-1250.00%
2018109.52%
2017-31.25%
2016-120.08%